CME appoints Boberski to develop OTC offering
David Boberski was today named managing director of over-the-counter research and new product development at the Chicago Mercantile Exchange (CME) Group.
In this newly created position Boberski will be responsible for developing CME's credit and interest rates OTC businesses. The derivatives exchange plans to launch a CDS clearing solution in the US in the first quarter of this year and is in discussions with regulators about adapting its existing European clearing platform to clear credit derivatives.
An official at the exchange declined to give a launch date, but told Risk that a delegation from CME had been present at Tuesday's meeting of market participants and European regulators and would follow the market consensus on European clearing.
However, in Europe, CME will have to compete with US rival IntercontinentalExchange, which announced on February 19 that it will clear European CDS contracts in the first half of the year, and NYSE Liffe, a London-based derivatives exchange that rolled-out a CDS clearing service on December 22, 2008.
In the US, CME was given the green light on December 23 to launch its CDS clearing service by the Commodity Futures Trading Commission and the Federal Reserve Bank of New York, but discussions are still ongoing with the Securities and Exchange Commission.
Before joining CME, Boberski was head of exchange-traded derivatives research at UBS, having previously worked at Bear Stearns as head of interest rate strategy. He will report to Julie Winkler, the managing director of research and product development.
See also: Eurex trading volume nudges ahead of CME
CME awaits SEC approval for CDS clearing
Portal combat
Breath of Liffe
LCH.Clearnet to expand CDS clearing into eurozone
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
More on People
People: Isda taps four new directors, O’Callaghan joins CA, Berlinski quits Goldman, and more
Latest job changes across the industry
People: Citi snags Raghavan, SocGen bags Estrada, all change at NYCB, and more
Latest job changes across the industry
Kane to leave Citadel Securities for senior Miax role
Options exchange has been on a four-year acquisition spree
Asia moves: senior hires at Millennium, Citi, SMBC and more
Latest job news from across the industry
Ken Pang set to join Millennium as Asia equities head
Former Credit Suisse markets co-head joins hedge fund’s Hong Kong office
People: Risk shake-up at Santander, JPM juggles markets, and more
Latest job changes across the industry
People: UBS rejigs EQD, risk head departs; Rustad joins buy side, and more
Latest job changes across the industry
Rustad re-emerges at Taula Capital
Former JP Morgan clearing head to help prepare for Q2 fund launch
Most read
- Top 10 operational risks for 2024
- Top 10 op risks: third parties stoke cyber risk
- Japanese megabanks shun internal models as FRTB bites